Terms: = Leukemia AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF
144 results:
1. Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic leukemia.
Cruz-Miranda GM; Olarte-Carrillo I; Bárcenas-López DA; Martínez-Tovar A; Ramírez-Bello J; Ramos-Peñafiel CO; García-Laguna AI; Cerón-Maldonado R; May-Hau D; Jiménez-Morales S
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339034
[TBL] [Abstract] [Full Text] [Related]
2. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
3. Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.
Sigvardsson M
Genes Dev; 2023 Aug; 37(15-16):703-723. PubMed ID: 37673459
[TBL] [Abstract] [Full Text] [Related]
4. ebf1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.
Kojima Y; Kawashima F; Yasuda T; Odaira K; Inagaki Y; Yamada C; Muraki A; Noura M; Okamoto S; Tamura S; Iwamoto E; Sanada M; Matsumura I; Miyazaki Y; Kojima T; Kiyoi H; Tsuzuki S; Hayakawa F
Int J Hematol; 2023 Jul; 118(1):65-74. PubMed ID: 37149540
[TBL] [Abstract] [Full Text] [Related]
5. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
[No Abstract] [Full Text] [Related]
6. Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
Parsons MW; Rock C; Chipman JJ; Shah HR; Hu B; Stephens DM; Tao R; Tward JD; Gaffney DK
Cancer Med; 2023 Feb; 12(3):2624-2636. PubMed ID: 36812123
[TBL] [Abstract] [Full Text] [Related]
7. INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors.
Moës B; Li H; Molina-Ortiz P; Radermecker C; Rosu A; Vande Catsyne CA; Sayyed SA; Fontela J; Duque M; Mostafa A; Azzi A; Barata JT; Merino R; Xu C; Desmet CJ; Schurmans S
Blood; 2023 Apr; 141(14):1708-1717. PubMed ID: 36599086
[TBL] [Abstract] [Full Text] [Related]
8. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract] [Full Text] [Related]
9. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
[TBL] [Abstract] [Full Text] [Related]
10. Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid leukemia: An ALWP/EBMT Analysis.
Nagler A; Ngoya M; Galimard JE; Labopin M; Bornhäuser M; Stelljes M; Finke J; Ganser A; Einsele H; Kröger N; Brecht A; Bethge W; Edinger M; Kulagin A; Passweg J; Blau IW; Elmaagacli A; Schäfer-Eckart K; Platzbecker U; Schroeder T; Bunjes D; Tischer J; Martin S; Spyridonidis A; Giebel S; Savani B; Mohty M
Clin Cancer Res; 2022 Oct; 28(19):4258-4266. PubMed ID: 35670780
[TBL] [Abstract] [Full Text] [Related]
11. Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
Venn NC; Huang L; Hovorková L; Muskovic W; Wong M; Law T; Heatley SL; Khaw SL; Revesz T; Dalla Pozza L; Shaw PJ; Fraser C; Moore AS; Cross S; Bendak K; Norris MD; Henderson MJ; White DL; Cowley MJ; Trahair TN; Zuna J; Sutton R
Br J Cancer; 2022 Sep; 127(5):908-915. PubMed ID: 35650277
[TBL] [Abstract] [Full Text] [Related]
12. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
Bayer M; Grosschedl R
Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
[TBL] [Abstract] [Full Text] [Related]
13. ebf1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.
Zhou Y; Petrovic J; Zhao J; Zhang W; Bigdeli A; Zhang Z; Berger SL; Pear WS; Faryabi RB
Mol Cell; 2022 Mar; 82(5):1003-1020.e15. PubMed ID: 35182476
[TBL] [Abstract] [Full Text] [Related]
14. Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation.
Lee RD; Munro SA; Knutson TP; LaRue RS; Heltemes-Harris LM; Farrar MA
Nat Commun; 2021 Nov; 12(1):6843. PubMed ID: 34824268
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Moorman AV; Barretta E; Butler ER; Ward EJ; Twentyman K; Kirkwood AA; Enshaei A; Schwab C; Creasey T; Leongamornlert D; Papaemmanuil E; Patrick P; Clifton-Hadley L; Patel B; Menne T; McMillan AK; Harrison CJ; Rowntree CJ; Marks DI; Fielding AK
Leukemia; 2022 Mar; 36(3):625-636. PubMed ID: 34657128
[TBL] [Abstract] [Full Text] [Related]
16. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
[TBL] [Abstract] [Full Text] [Related]
17. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
[TBL] [Abstract] [Full Text] [Related]
18. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
[TBL] [Abstract] [Full Text] [Related]
19. Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up.
Casper AC; Parsons MW; Chipman J; Burt LM; Suneja G; Maurer KA; Gaffney DK
Gynecol Oncol; 2021 Aug; 162(2):454-460. PubMed ID: 34092413
[TBL] [Abstract] [Full Text] [Related]
20. [The basophil: From control of immunity to control of leukemias].
Arock M
Ann Pharm Fr; 2022 Jan; 80(1):9-25. PubMed ID: 34051212
[TBL] [Abstract] [Full Text] [Related]
[Next]
